Epigral Ltd
Epigral Ltd Share Price Today: Live Updates & Key Insights
Get insights on Epigral Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Epigral Ltd Share Price Chart
Epigral Ltd Fundamentals
Traded Volume: 22,159
Market Cap(Cr): 6,263
Avg Traded Price 1455.03
1 Year return -24.74%
Upper Circuit 1,475
Lower Circuit 1,442.1
P/E TTM 16.00
P/B Ratio 93.00
Traded Value(Cr) 321.70
EPS TTM 93.282
Book value 93.282
Dividend 0.00%
Epigral Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Epigral Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Epigral Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -5.17%
1M -13.90%
3M -22.05%
1Y -24.74%
YTD -22.35%
Epigral Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Epigral Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 12246.00
Day Before Yesterday 18946.00
1W Avg 15986.80
1M Avg 29736.38
3M Avg 24385.16
Epigral Ltd Technical Details
Epigral Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 1438
Support 2 1423
Support 3 1405
Pivot Point : 1456
Resistance 1 1471
Resistance 2 1489
Resistance 3 1503
Epigral Ltd Corporate Actions
Epigral Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Epigral Ltd’s capital allocation strategies.
All
Ex-Date 20-Jun-2025 Type D Description 3.50/share@35.00% Record Date 21-Jun-2025 Ratio 35.00
Ex-Date 07-Feb-2025 Type D Description 2.50/share@25.00% Record Date 07-Feb-2025 Ratio 25.00
Ex-Date 02-Jul-2024 Type D Description 5.00/share@50.00% Record Date 02-Jul-2024 Ratio 50.00
Ex-Date 20-Jun-2023 Type D Description 2.50/share@25.00% Record Date 20-Jun-2023 Ratio 25.00
Ex-Date 01-Feb-2023 Type D Description 2.50/share@25.00% Record Date 01-Feb-2023 Ratio 25.00
Dividends
Announcement Date 20-Jun-2025 Ex Dividend Date 20-Jun-2025 Dividend(%) 35
Announcement Date 07-Feb-2025 Ex Dividend Date 07-Feb-2025 Dividend(%) 25
Announcement Date 02-Jul-2024 Ex Dividend Date 02-Jul-2024 Dividend(%) 50
Announcement Date 20-Jun-2023 Ex Dividend Date 20-Jun-2023 Dividend(%) 25
Announcement Date 01-Feb-2023 Ex Dividend Date 01-Feb-2023 Dividend(%) 25
Bonus
No Bonus has been declared by EPIGRAL
Splits
No Split has been declared by EPIGRAL
Others
Rights No Rights has been declared by EPIGRAL
Epigral Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Epigral Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Epigral Ltd's relative performance and valuation against major competitors.
Stock Name Alkyl Amines Chemicals Ltd ₹1747.20 (-1.59%) M. Cap (Cr) 89.36 1 Yr Return (%) -8.63% P/E (TTM) 49.06 PB Ratio 6.37
Stock Name Elantas Beck India Ltd ₹9256.10 (+0.46%) M. Cap (Cr) 73.38 1 Yr Return (%) -27.86% P/E (TTM) 53.49 PB Ratio 8.52
Stock Name Galaxy Surfactants Ltd ₹2062.20 (-2.24%) M. Cap (Cr) 73.11 1 Yr Return (%) -23.68% P/E (TTM) 25.52 PB Ratio 3.22
Stock Name Epigral Ltd ₹1451.80 (-0.24%) M. Cap (Cr) 62.63 1 Yr Return (%) -24.74% P/E (TTM) 15.56 PB Ratio 3.29
Stock Name Laxmi Organic Industries Ltd ₹182.74 (-0.34%) M. Cap (Cr) 50.65 1 Yr Return (%) -25.69% P/E (TTM) 60.67 PB Ratio 2.66
Stock Name Chemplast Sanmar Ltd ₹308.45 (-2.54%) M. Cap (Cr) 48.77 1 Yr Return (%) -36.76% P/E (TTM) -22.34 PB Ratio 44.04
Stock Name Balaji Amines Ltd ₹1179.10 (-1.37%) M. Cap (Cr) 38.20 1 Yr Return (%) -40.58% P/E (TTM) 26.20 PB Ratio 2.16
Epigral Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Epigral Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 440.56 Mar 2024 397.69 Mar 2023 626.16 Mar 2022 283.82 Mar 2021 229.22
PARTICULARS Investing Activities Mar 2025 -261.56 Mar 2024 -401.10 Mar 2023 -437.22 Mar 2022 -454.68 Mar 2021 -196.73
PARTICULARS Financing Activities Mar 2025 -163.54 Mar 2024 -7.60 Mar 2023 -199.79 Mar 2022 195.22 Mar 2021 -31.90
PARTICULARS Net Cash Flow Mar 2025 15.46 Mar 2024 -11.01 Mar 2023 -10.85 Mar 2022 24.36 Mar 2021 0.58
Epigral Ltd Shareholding Pattern
This shows the ownership breakdown of Epigral Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 68.83%
Public 23.52%
Other Institutions 0.21%
FII 2.71%
Mutual Funds 4.74%
About Epigral Ltd
Epigral Limited was erstwhile incorporated as 'Meghmani Finechem Limited' in 2007, which is engaged in manufacturing and selling of Chlor Alkali & its Derivatives and also in Trading of Agrochemical products. The Company was incorporated as a subsidiary of Meghmani Organics Limited. Meghmani Finechem Limited (MFL) was demerged from Meghmani Organics Limited (MOL) as a going concern, through the Scheme of Arrangement for Demerger and the said Scheme became effective from May 10, 2021. The Chlor-Alkali business commissioned in 2009, growing from an installed capacity of 1,88,000 TPA in 2015 to 3,15,000 TPA at the close of FY 2020-21. The Company is now among the leading players in India's chlor alkali industry. In terms of the said Scheme, the Company allotted 2,39,03,029 Equity Shares of Rs 10/- each on 20th May, 2021 to the shareholders of Meghmani Organics Limited.The Company grew its business following the commissioning of new plants (Caustic Soda, Hydrogen Peroxide and the 36 MW Captive Power Plant). The timely commissioning of the plants represented the faith of the management in the long-term potential of the sector and country. The Caustic Soda capacity was expanded by 1,27,000 TPA to 2,94,000 TPA and commissioned in June 2020. The Captive Power Plant capacity was increased by 36 MW to 96 MW, commissioned in June 2020. The Company commissioned a 60,000 TPA Hydrogen Peroxide plant in July 2020. The Company further commissioned the capacity expansion of Caustic Soda manufacturing facility to 400 KTPA by adding 106 KTPA facility, along with expansion of 36 MW Captive Power Plant on 30th September, 2022. It commissioned Epichlorohydrin (ECH) manufacturing facility with a capacity of 50,000 TPA on 1st June, 2022, which is used in varied applications, such as Epoxy Resin, Water Treatment Chemicals, Textiles, Pharmaceuticals, Paper Reinforcement, Synthetic Glycerine, etc. It commissioned CPVC Resinmanufacturing facility with a capacity of 30,000 TPA capacity on 18th July, 2022.In 2024-25, Company commissioned additional capacity of 45,000 TPA of CPVC Resin facility in April, 2024, reaching total capacity of CPVC Resin to 75,000 TPA. It also forward integrated and commissioned CPVC Compound facility of 35,000 TPA in June, 2024. Company has announced expansion of additional 75,000 TPA capacity of CPVC Resin plant at its Dahej facility in Gujarat. With this expansion, Company's total CPVC resin capacity reaches a remarkable 1,50,000 TPA in FY25. Company has commissioned India's First Chlorotoluenes Value Chain Facility at its Dahej Complex in Gujarat on 24th March, 2025.
Chairman & Managing Director
Maulik Jayantibhai Patel
Registered office CH/1 CH/2 GIDC Indl Estate, Dahej Tal Vagra, Bharuch, Gujarat, 392130
FAX :91-79-71761000-29709600
Background
Incorporation Year 2007
Face Value ₹10.00
Market Lot 1
FAQs on Epigral Ltd
How to buy Epigral Ltd shares on NSE?
To buy Epigral Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Epigral Ltd share price today?
The Epigral Ltd share price on NSE is ₹1451.80 today.
What is the market cap of Epigral Ltd on NSE?
The company has a market capitalization of ₹6263.26.
What is the PE & PB ratio of Epigral Ltd?
PE is 16 and PB is 93.
What is the 52 Week High and Low of Epigral Ltd shares?
Epigral Ltd stock price high: ₹2180 Epigral Ltd stock price low: ₹1440.